An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)
Status:
Terminated
Trial end date:
2011-06-30
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to assess the long-term safety of lusutrombopag in
the treatment of adults with relapsed persistent or chronic ITP with or without prior
splenectomy.